Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset.

Nishiyama S, Ito T, Misu T, Takahashi T, Kikuchi A, Suzuki N, Jin K, Aoki M, Fujihara K, Itoyama Y.

Neurology. 2009 Jun 2;72(22):1960-1. doi: 10.1212/WNL.0b013e3181a82621. No abstract available.

PMID:
19487655
2.

Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody.

Baba T, Nakashima I, Kanbayashi T, Konno M, Takahashi T, Fujihara K, Misu T, Takeda A, Shiga Y, Ogawa H, Itoyama Y.

J Neurol. 2009 Feb;256(2):287-8. doi: 10.1007/s00415-009-0139-4. Epub 2009 Mar 5. No abstract available.

PMID:
19266146
3.

Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.

Saikali P, Cayrol R, Vincent T.

Autoimmun Rev. 2009 Dec;9(2):132-5. doi: 10.1016/j.autrev.2009.04.004. Epub 2009 Apr 21. Review.

PMID:
19389490
4.

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y.

Brain. 2007 May;130(Pt 5):1235-43. Epub 2007 Apr 19.

PMID:
17449477
5.

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR.

J Exp Med. 2005 Aug 15;202(4):473-7. Epub 2005 Aug 8.

6.

Complexity and heterogeneity in demyelinating disease.

Compston A.

Brain. 2007 May;130(Pt 5):1178-80. No abstract available.

PMID:
17472981
7.

Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment.

Vincent T, Saikali P, Cayrol R, Roth AD, Bar-Or A, Prat A, Antel JP.

J Immunol. 2008 Oct 15;181(8):5730-7.

8.

NMO-IgG detected in CSF in seronegative neuromyelitis optica.

Klawiter EC, Alvarez E 3rd, Xu J, Paciorkowski AR, Zhu L, Parks BJ, Cross AH, Naismith RT.

Neurology. 2009 Mar 24;72(12):1101-3. doi: 10.1212/01.wnl.0000345066.57745.50. No abstract available.

9.

Recurrent spinal cord attacks in a patient with a limited form of neuromyelitis optica.

Matsumoto H, Shimizu T, Okabe S, Konoma Y, Takahashi T, Hirakawa-Yamada M, Igeta Y, Hashida H.

Intern Med. 2011;50(5):509-13. Epub 2011 Mar 1.

11.

The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan.

Wang KC, Tsai CP, Lee CL, Chen SY, Chen SJ.

Eur Neurol. 2011;65(2):99-104. doi: 10.1159/000322740. Epub 2011 Jan 27.

PMID:
21273778
12.

[Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].

Misu T, Fujihara K, Itoyama Y.

Brain Nerve. 2008 May;60(5):527-37. Review. Japanese.

PMID:
18516975
13.

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.

Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF.

Brain. 2007 May;130(Pt 5):1194-205. Epub 2007 Feb 4.

PMID:
17282996
14.

Neuromyelitis optica.

Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG.

Curr Opin Neurol. 2007 Jun;20(3):255-60. Review.

PMID:
17495617
15.

Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.

Cayrol R, Saikali P, Vincent T.

Ann N Y Acad Sci. 2009 Sep;1173:478-86. doi: 10.1111/j.1749-6632.2009.04871.x. Review.

PMID:
19758189
16.

CNS aquaporin-4 autoimmunity in children.

McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, Kuntz NL, Fryer JP, Homburger H, Hunter J, Weinshenker BG, Krecke K, Lucchinetti CF, Pittock SJ.

Neurology. 2008 Jul 8;71(2):93-100. doi: 10.1212/01.wnl.0000314832.24682.c6. Epub 2008 May 28.

PMID:
18509092
17.

Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.

Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, Minohara M, Kikuchi H, Mihara F, Ohyagi Y, Kira J.

Brain. 2007 May;130(Pt 5):1206-23. Epub 2007 Apr 17.

PMID:
17439988
18.

Neuromyelitis optica with HTLV-1 infection: different from acute progressive HAM?

Koga M, Takahashi T, Kawai M, Negoro K, Kanda T.

Intern Med. 2009;48(13):1157-9. Epub 2009 Jul 1.

19.

Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.

Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ.

Arch Neurol. 2009 Sep;66(9):1164-7. doi: 10.1001/archneurol.2009.188.

PMID:
19752309
20.

[Devic's neuromyelitis optica: an evolving concept].

de Seze J.

Rev Neurol (Paris). 2006 May;162(5):565-6. French. No abstract available.

PMID:
16710122

Supplemental Content

Support Center